Search

Search Constraints

You searched for: Author/Creator Kita, Yuki

Search Results

1. A novel case presenting with an unusual ureteral diverticular lesion similar to adenomyomatous hyperplasia of the gallbladder. Issue 3 (19th January 2016)

2. Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer. Issue 9 (29th July 2021)

4. Bladder urothelial carcinoma producing insulin‐like growth factor II: A case report. Issue 1 (20th September 2018)

5. Circulating selenoprotein P levels predict glucose‐lowering and insulinotropic effects of metformin, but not alogliptin: A post‐hoc analysis. Issue 2 (7th December 2022)

6. Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre‐enfortumab vedotin era. (18th March 2022)

7. Corrigendum to 'Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities'. Issue 7 (July 2017)

8. Development of a Sol Particle Homogeneous Immunoassay for Measuring Full‐Length Selenoprotein P in Human Serum. Issue 2 (26th December 2014)

9. Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study. (21st July 2022)

10. Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis. (6th May 2019)